by Clinical Neuropsychologist | Tuesday, July 23, 2024 | Dementia
Abstract INTRODUCTION Cerebrospinal fluid (CSF) tau phosphorylation at multiple sites is associated with cortical amyloid and other pathologic changes in Alzheimer’s disease. These relationships can be non-linear. We used an artificial neural network to assess...
by Clinical Neuropsychologist | Tuesday, July 23, 2024 | Dementia
Abstract INTRODUCTION Understanding attitudes toward participation among diverse preclinical Alzheimer’s disease (AD) trial participants could yield insights to instruct future recruitment. METHODS Using data from the Anti-Amyloid Treatment in Asymptomatic AD...
by Clinical Neuropsychologist | Tuesday, July 23, 2024 | Dementia
Abstract INTRODUCTION Understanding early neuropathological changes and their associations with cognition may aid dementia prevention. This study investigated associations of cerebral amyloid and tau positron emission tomography (PET) retention with cognition in a...
by Clinical Neuropsychologist | Tuesday, July 23, 2024 | Dementia
Dementia, Volume 23, Issue 7, Page 1126-1151, October 2024. Background: This paper uses Normalization Process Theory (NPT) to examine staff impressions of Montessori-based program training and implementation at Veterans Affairs Community Living Centers (VA CLCs;...
by Clinical Neuropsychologist | Monday, July 22, 2024 | Dementia
Abstract A Nature Medicine paper published in January 2024 describes eight cases of iatrogenic Alzheimer’s disease in individuals who received cadaveric pituitary-derived human growth hormone. The paper’s conclusions argue for the transmissibility of...